Skip to main content
Top
Gepubliceerd in:

11-07-2015 | Artikel

Executieve disfuncties bij patiënten met de ziekte van Parkinson: een aantal nieuwe perspectieven

Auteurs: Janneke Koerts, Lara Tucha, Oliver Tucha

Gepubliceerd in: Neuropraxis | Uitgave 5/2015

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Samenvatting

De ziekte van Parkinson is een progressieve neurodegeneratieve aandoening die wordt gekenmerkt door beperkingen in het executief functioneren. Het executief functioneren speelt een belangrijke rol bij de regulatie van cognitie, emotie en gedrag, en hoewel al veel bekend is over de executieve disfuncties van patiënten met de ziekte van Parkinson, is verdere exploratie noodzakelijk. Het huidige artikel beschrijft drie studies die zich richten op: (1) wat wordt gemeten met Verbale Fluency Tests (VFT’s) bij patiënten met de ziekte van Parkinson, (2) het meten van het executief functioneren in het dagelijks leven van Parkinson-patiënten en (3) in hoeverre Parkinson-patiënten zich bewust zijn van en inzicht hebben in hun executieve disfuncties.
Literatuur
1.
go back to reference Schrag A. Quality of life and depression in Parkinson’s disease. J Neurol Sci. 2006;248(1–2):151–7.CrossRefPubMed Schrag A. Quality of life and depression in Parkinson’s disease. J Neurol Sci. 2006;248(1–2):151–7.CrossRefPubMed
2.
go back to reference Klepac N, Trkulja V, Relja M, Babic T. Is quality of life in non-demented Parkinson’s disease patients related to cognitive performance? A clinic-based cross-sectional study. Eur J Neurol. 2008;15(2):128–33.CrossRefPubMed Klepac N, Trkulja V, Relja M, Babic T. Is quality of life in non-demented Parkinson’s disease patients related to cognitive performance? A clinic-based cross-sectional study. Eur J Neurol. 2008;15(2):128–33.CrossRefPubMed
3.
go back to reference Klepac N, Hajnsek S, Trkulja V. Impact of pre-morbid depression on health-related quality of life in non-demented Parkinson’s disease patients. Parkinsonism Relat Disord. 2010;16(1):21–7.CrossRefPubMed Klepac N, Hajnsek S, Trkulja V. Impact of pre-morbid depression on health-related quality of life in non-demented Parkinson’s disease patients. Parkinsonism Relat Disord. 2010;16(1):21–7.CrossRefPubMed
4.
go back to reference Zis P, Rizos A, Martinez-Martin P, Pal S, Silverdale M, Sharma JC, et al. Non-motor symptoms profile and burden in drug naive versus long-term Parkinson’s disease patients. J Parkinsons Dis. 2014;4(3):541–7.PubMed Zis P, Rizos A, Martinez-Martin P, Pal S, Silverdale M, Sharma JC, et al. Non-motor symptoms profile and burden in drug naive versus long-term Parkinson’s disease patients. J Parkinsons Dis. 2014;4(3):541–7.PubMed
5.
go back to reference Starkstein SE, Brockman S, Hayhow BD. Psychiatric syndromes in Parkinson’s disease. Curr Opin Psychiatry. 2012;25(6):468–72.CrossRefPubMed Starkstein SE, Brockman S, Hayhow BD. Psychiatric syndromes in Parkinson’s disease. Curr Opin Psychiatry. 2012;25(6):468–72.CrossRefPubMed
6.
go back to reference Leentjens AF, Akker M Van den, Metsemakers JF, Lousberg R, Verhey FR. Higher incidence of depression preceding the onset of Parkinson’s disease: a register study. Mov Disord. 2003;18(0885–3185; 4):414–8.CrossRefPubMed Leentjens AF, Akker M Van den, Metsemakers JF, Lousberg R, Verhey FR. Higher incidence of depression preceding the onset of Parkinson’s disease: a register study. Mov Disord. 2003;18(0885–3185; 4):414–8.CrossRefPubMed
7.
go back to reference Koerts J, Borg MA, Meppelink AM, Leenders KL, Beilen M van, Laar T van. Attentional and perceptual impairments in Parkinson’s disease with visual hallucinations. Parkinsonism Relat Disord. 2010;16(4):270–4.CrossRefPubMed Koerts J, Borg MA, Meppelink AM, Leenders KL, Beilen M van, Laar T van. Attentional and perceptual impairments in Parkinson’s disease with visual hallucinations. Parkinsonism Relat Disord. 2010;16(4):270–4.CrossRefPubMed
8.
go back to reference Leentjens AF, Dujardin K, Marsh L, Martinez-Martin P, Richard IH, Starkstein SE. Symptomatology and markers of anxiety disorders in Parkinson’s disease: a cross-sectional study. Mov Disord. 2011;26(3):484–92.CrossRefPubMed Leentjens AF, Dujardin K, Marsh L, Martinez-Martin P, Richard IH, Starkstein SE. Symptomatology and markers of anxiety disorders in Parkinson’s disease: a cross-sectional study. Mov Disord. 2011;26(3):484–92.CrossRefPubMed
9.
go back to reference Friedman JH, Brown RG, Comella C, Garber CE, Krupp LB, Lou JS, et al. Fatigue in Parkinson’s disease: a review. Mov Disord. 2007;22(0885–3185; 3):297–308.CrossRefPubMed Friedman JH, Brown RG, Comella C, Garber CE, Krupp LB, Lou JS, et al. Fatigue in Parkinson’s disease: a review. Mov Disord. 2007;22(0885–3185; 3):297–308.CrossRefPubMed
10.
go back to reference Dujardin K, Sockeel P, Devos D, Delliaux M, Krystkowiak P, Destee A, et al. Characteristics of apathy in Parkinson’s disease. Mov Disord. 2007;22(0885–3185; 6):778–84.CrossRefPubMed Dujardin K, Sockeel P, Devos D, Delliaux M, Krystkowiak P, Destee A, et al. Characteristics of apathy in Parkinson’s disease. Mov Disord. 2007;22(0885–3185; 6):778–84.CrossRefPubMed
11.
go back to reference Koerts J, Leenders KL, Brouwer WH. Cognitive dysfunction in non-demented Parkinson’s disease patients: controlled and automatic behavior. Cortex. 2009;45(0010–9452; 8):922–9.CrossRefPubMed Koerts J, Leenders KL, Brouwer WH. Cognitive dysfunction in non-demented Parkinson’s disease patients: controlled and automatic behavior. Cortex. 2009;45(0010–9452; 8):922–9.CrossRefPubMed
12.
go back to reference Muslimovic D, Schmand B, Speelman JD, Haan RJ de. Course of cognitive decline in Parkinson’s disease: a meta-analysis. J Int Neuropsychol Soc. 2007;13(6):920–32.CrossRefPubMed Muslimovic D, Schmand B, Speelman JD, Haan RJ de. Course of cognitive decline in Parkinson’s disease: a meta-analysis. J Int Neuropsychol Soc. 2007;13(6):920–32.CrossRefPubMed
13.
go back to reference Koerts, J., Tucha, O. Cognitief functioneren bij patiënten met de ziekte van Parkinson. Tijdschrift voor Neuropsychologie. 2014;9:89–93. Koerts, J., Tucha, O. Cognitief functioneren bij patiënten met de ziekte van Parkinson. Tijdschrift voor Neuropsychologie. 2014;9:89–93.
14.
go back to reference Strauss E, Sherman EMS, Spreen O. A compendium of neuropsychological tests. 3rd edn. New York: Oxford university press; 2006. Strauss E, Sherman EMS, Spreen O. A compendium of neuropsychological tests. 3rd edn. New York: Oxford university press; 2006.
15.
go back to reference Muslimovic D, Post B, Speelman JD, Schmand B. Cognitive profile of patients with newly diagnosed Parkinson disease. Neurology. 2005;65(1526–632; 8):1239–45.CrossRefPubMed Muslimovic D, Post B, Speelman JD, Schmand B. Cognitive profile of patients with newly diagnosed Parkinson disease. Neurology. 2005;65(1526–632; 8):1239–45.CrossRefPubMed
16.
go back to reference Rymer S, Salloway S, Norton L, Malloy P, Correia S, Monast D. Impaired awareness, behavior disturbance, and caregiver burden in Alzheimer disease. Alzheimer Dis Assoc Disord. 2002;16(4):248–53.CrossRefPubMed Rymer S, Salloway S, Norton L, Malloy P, Correia S, Monast D. Impaired awareness, behavior disturbance, and caregiver burden in Alzheimer disease. Alzheimer Dis Assoc Disord. 2002;16(4):248–53.CrossRefPubMed
17.
go back to reference Seltzer B, Vasterling JJ, Yoder JA, Thompson KA. Awareness of deficit in Alzheimer’s disease: relation to caregiver burden. Gerontologist. 1997;37(1):20–4.CrossRefPubMed Seltzer B, Vasterling JJ, Yoder JA, Thompson KA. Awareness of deficit in Alzheimer’s disease: relation to caregiver burden. Gerontologist. 1997;37(1):20–4.CrossRefPubMed
18.
go back to reference Williams-Gray CH, Evans JR, Goris A, Foltynie T, Ban M, Robbins TW, et al. The distinct cognitive syndromes of Parkinson’s disease: 5 year follow-up of the CamPaIGN cohort. Brain. 2009;132(Pt 11):2958–69.CrossRefPubMed Williams-Gray CH, Evans JR, Goris A, Foltynie T, Ban M, Robbins TW, et al. The distinct cognitive syndromes of Parkinson’s disease: 5 year follow-up of the CamPaIGN cohort. Brain. 2009;132(Pt 11):2958–69.CrossRefPubMed
19.
go back to reference Koerts J, Meijer HA, Colman KS, Tucha L, Lange KW, Tucha O. What is measured with verbal fluency tests in Parkinson’s disease patients at different stages of the disease? J Neural Transm. 2013;120(3):403–11.CrossRefPubMed Koerts J, Meijer HA, Colman KS, Tucha L, Lange KW, Tucha O. What is measured with verbal fluency tests in Parkinson’s disease patients at different stages of the disease? J Neural Transm. 2013;120(3):403–11.CrossRefPubMed
20.
go back to reference Unsworth N, Spillers GJ, Brewer GA. Variation in verbal fluency: a latent variable analysis of clustering, switching, and overall performance. Q J Exp Psychol (Hove). 2011;64(3):447–66.CrossRef Unsworth N, Spillers GJ, Brewer GA. Variation in verbal fluency: a latent variable analysis of clustering, switching, and overall performance. Q J Exp Psychol (Hove). 2011;64(3):447–66.CrossRef
21.
go back to reference Muslimovic D, Post B, Speelman JD, Haan RJ De, Schmand B. Cognitive decline in Parkinson’s disease: a prospective longitudinal study. J Int Neuropsychol Soc. 2009;15(3):426–37.CrossRefPubMed Muslimovic D, Post B, Speelman JD, Haan RJ De, Schmand B. Cognitive decline in Parkinson’s disease: a prospective longitudinal study. J Int Neuropsychol Soc. 2009;15(3):426–37.CrossRefPubMed
22.
go back to reference Eslinger PJ, Damasio AR. Severe disturbance of higher cognition after bilateral frontal lobe ablation: patient EVR. Neurology. 1985;35(12):1731–41.CrossRefPubMed Eslinger PJ, Damasio AR. Severe disturbance of higher cognition after bilateral frontal lobe ablation: patient EVR. Neurology. 1985;35(12):1731–41.CrossRefPubMed
23.
go back to reference Shallice T, Burgess PW. Deficits in strategy application following frontal lobe damage in man. Brain. 1991;114(0006–8950; Pt 2):727–41.CrossRefPubMed Shallice T, Burgess PW. Deficits in strategy application following frontal lobe damage in man. Brain. 1991;114(0006–8950; Pt 2):727–41.CrossRefPubMed
24.
go back to reference Beilen M van, Zomeren EH van, Bosch RJ van den, Withaar FK, Bouma A. Measuring the executive functions in schizophrenia: the voluntary allocation of effort. J Psychiatr Res. 2005;39(0022–3956; 6):585–93.CrossRefPubMed Beilen M van, Zomeren EH van, Bosch RJ van den, Withaar FK, Bouma A. Measuring the executive functions in schizophrenia: the voluntary allocation of effort. J Psychiatr Res. 2005;39(0022–3956; 6):585–93.CrossRefPubMed
25.
go back to reference Koerts J, Beilen M van, Tucha O, Leenders KL, Brouwer WH. Executive functioning in daily life in Parkinson’s disease: initiative, planning and multi-task performance. PLoS One. 2011;6(12):e29254.PubMedCentralCrossRefPubMed Koerts J, Beilen M van, Tucha O, Leenders KL, Brouwer WH. Executive functioning in daily life in Parkinson’s disease: initiative, planning and multi-task performance. PLoS One. 2011;6(12):e29254.PubMedCentralCrossRefPubMed
26.
go back to reference Bialystok E, Craik FI, Stefurak T. Planning and task management in Parkinson’s disease: differential emphasis in dual-task performance. J Int Neuropsychol Soc. 2008;14(1469–7661; 2):257–65.CrossRefPubMed Bialystok E, Craik FI, Stefurak T. Planning and task management in Parkinson’s disease: differential emphasis in dual-task performance. J Int Neuropsychol Soc. 2008;14(1469–7661; 2):257–65.CrossRefPubMed
27.
go back to reference Alcalay RN, Mejia-Santana H, Tang MX, Rakitin B, Rosado L, Ross B, et al. Self-report of cognitive impairment and mini-mental state examination performance in PRKN, LRRK2, and GBA carriers with early onset Parkinson’s disease. J Clin Exp Neuropsychol. 2010;24:1–5.CrossRef Alcalay RN, Mejia-Santana H, Tang MX, Rakitin B, Rosado L, Ross B, et al. Self-report of cognitive impairment and mini-mental state examination performance in PRKN, LRRK2, and GBA carriers with early onset Parkinson’s disease. J Clin Exp Neuropsychol. 2010;24:1–5.CrossRef
28.
go back to reference Marino SE, Meador KJ, Loring DW, Okun MS, Fernandez HH, Fessler AJ, et al. Subjective perception of cognition is related to mood and not performance. Epilepsy Behav. 2009;14(3):459–64.PubMedCentralCrossRefPubMed Marino SE, Meador KJ, Loring DW, Okun MS, Fernandez HH, Fessler AJ, et al. Subjective perception of cognition is related to mood and not performance. Epilepsy Behav. 2009;14(3):459–64.PubMedCentralCrossRefPubMed
29.
go back to reference Dujardin K, Duhamel A, Delliaux M, Thomas-Anterion C, Destee A, Defebvre L. Cognitive complaints in Parkinson’s disease: its relationship with objective cognitive decline. J Neurol. 2010;257(1):79–84.CrossRefPubMed Dujardin K, Duhamel A, Delliaux M, Thomas-Anterion C, Destee A, Defebvre L. Cognitive complaints in Parkinson’s disease: its relationship with objective cognitive decline. J Neurol. 2010;257(1):79–84.CrossRefPubMed
30.
go back to reference Koerts J, Beilen M van, Leenders KL, Brouwer WH, Tucha L, Tucha O. Complaints about impairments in executive functions in Parkinson’s disease: the association with neuropsychological assessment. Parkinsonism Relat Disord. 2012;18(2):194–7.CrossRefPubMed Koerts J, Beilen M van, Leenders KL, Brouwer WH, Tucha L, Tucha O. Complaints about impairments in executive functions in Parkinson’s disease: the association with neuropsychological assessment. Parkinsonism Relat Disord. 2012;18(2):194–7.CrossRefPubMed
31.
go back to reference Williamson C, Alcantar O, Rothlind J, Cahn-Weiner D, Miller BL, Rosen HJ. Standardised measurement of self-awareness deficits in FTD and AD. J Neurol Neurosurg Psychiatry. 2010;81(2):140–5.PubMedCentralCrossRefPubMed Williamson C, Alcantar O, Rothlind J, Cahn-Weiner D, Miller BL, Rosen HJ. Standardised measurement of self-awareness deficits in FTD and AD. J Neurol Neurosurg Psychiatry. 2010;81(2):140–5.PubMedCentralCrossRefPubMed
32.
go back to reference Vlagsma TT, Koerts J, Fasotti L, Tucha O, Laar T van, Dijkstra H, et al. Parkinson’s patients’ executive profile and goals they set for improvement: why is cognitive rehabilitation not common practice? Neuropsychol Rehabil. 2015;19:1–20.CrossRef Vlagsma TT, Koerts J, Fasotti L, Tucha O, Laar T van, Dijkstra H, et al. Parkinson’s patients’ executive profile and goals they set for improvement: why is cognitive rehabilitation not common practice? Neuropsychol Rehabil. 2015;19:1–20.CrossRef
33.
go back to reference Vlagsma TT, Spikman JM. Review: Neuropsychologische behandelingen voor patiënten met de ziekte van Parkinson. Tijdschr voor Neuropsychol. 2014;9:128–43. Vlagsma TT, Spikman JM. Review: Neuropsychologische behandelingen voor patiënten met de ziekte van Parkinson. Tijdschr voor Neuropsychol. 2014;9:128–43.
Metagegevens
Titel
Executieve disfuncties bij patiënten met de ziekte van Parkinson: een aantal nieuwe perspectieven
Auteurs
Janneke Koerts
Lara Tucha
Oliver Tucha
Publicatiedatum
11-07-2015
Uitgeverij
Bohn Stafleu van Loghum
Gepubliceerd in
Neuropraxis / Uitgave 5/2015
Print ISSN: 1387-5817
Elektronisch ISSN: 1876-5785
DOI
https://doi.org/10.1007/s12474-015-0096-x

Andere artikelen Uitgave 5/2015

Neuropraxis 5/2015 Naar de uitgave